A biotech company developing immunomodulatory therapies asked Alacrita to assess the possible applications of its lead product, particularly in the context of improving the efficacy of other mAb therapeutics as anti-cancer drugs.


One of Alacrita's oncology experts performed a review of the oncology landscape, including approved and development stage drugs. Our expert identified several possible applications, with a view that initial clinical development should focus on combining the drug with already approved mAbs for several cancer indications. We delivered a report including recommendations for top-level development strategies using the new drug in combination with approved mAbs, flagging the associated risks, and triaging the opportunities for those that would allow early proof-of-concept. 

Opportunity Mapping Services

We can help you gauge and rank the opportunities for your R&D programs or technology platforms to deliver value, by framing the commercial potential and charting the path to market.

Contact Us

Reach out today for more information on our opportunity mapping services.

Additional Opportunity Mapping Case Studies